Your SlideShare is downloading. ×
0
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Selective oestogen receptor modulators
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Selective oestogen receptor modulators

1,066

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,066
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
85
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Estradiol (E) binds with high affinity to estrogen receptor (ER) and dissociates heat shock protein 90 (HSP90) E-ER complex homodimerizes and localizes preferentially in the cell nucleus E-ER homodimer binds DNA sequence at palindromic estrogen response element (ERE) in the promotor region of estrogen-sensitive genes Activation of transcription by ER involves interaction of the transcription activation functions of ER, AF1 and AF2 with transcriptional coactivators to stimulate the activity of RNA polymerase II (RNA POL II)
  • Tamoxifen (T) binds to ER with low affinity compared with estradiol (E) and dissociates heat shock protein 90 (HSP90) T-ER complex homodimerizes and translocates to the cell nucleus, and activation function (AF1) (but not AF2) is active T-ER dimer binds DNA to sequence at palindromic ERE in the promotor region of estrogen-sensitive genes Transcription of E-responsive genes(s) is attenuated because AF2 is inactive, and coactivator binding is attenuated by the T-ER complex; partial agonist activity results from AF1, which remains active in the T-ER complex
  • Estradiol (E) binds with high affinity to estrogen receptor (ER) and dissociates heat shock protein 90 (HSP90) E-ER complex homodimerizes and localizes preferentially in the cell nucleus E-ER homodimer binds DNA sequence at palindromic estrogen response element (ERE) in the promotor region of estrogen-sensitive genes Activation of transcription by ER involves interaction of the transcription activation functions of ER, AF1 and AF2 with transcriptional coactivators to stimulate the activity of RNA polymerase II (RNA POL II)
  • Transcript

    • 1. SELECTIVE ESTROGEN RECEPTOR MODULATORS
    • 2. www.freelivedoctor.com Estrogen
    • 3. <ul><li>That Nourishes & Nurtures womanhood </li></ul>www.freelivedoctor.com The Feminine Hormone Estrogen
    • 4. www.freelivedoctor.com Effects of Estrogen at Various Sites in the Body Tissue Effect of Estrogen Stimulation Clinical Effect of Stimulation Clinical Effect of Absence of Stimulation Bone Increased deposits of calcium into bone Increased bone density Osteoporosis Brain Blocks the release of ovarian estrogen None Hot flashes, sleep disorders, mood changes, problems with memory? Alzheimer’s disease?? Breast Stimulates growth of breast tissue Bigger breasts,? Increased risk of breast cancer, increased sensitivity of the breast, Smaller breasts Blood Clotting Increased risk of blood clots No change in clotting Blood Fats Increased HDL, decreased LDL, decreased Cholesterol, Decreased HDL, increased LDL, increased Cholesterol Skin Increased fat deposits in skin Softer skin Thinner skin, liver spots, dry skin Uterus Increased stimulation of uterine lining and muscle Heavier cycles, increased risk of uterine cancer No periods Vagina Increased thickening of skin, better blood supply to tissue Vaginal discharge, feelings of pelvic congestion Dryness, vaginal infections, painful sex, incontinence of urine, pelvic weakness
    • 5. Molecular Action of Estrogen www.freelivedoctor.com Adopted from George et al hsp90 – heat shock protein90
    • 6. Molecular Action of Estrogen www.freelivedoctor.com Adopted from Stanley J Birge et al AP I – activator protein CRP – co regulator protein ER – estrogen receptor ERE – estrogen response element Poly II – polymerase II TATA- adenine-thymine-rich sequence important for gene transcription
    • 7. Estrogen Receptor www.freelivedoctor.com Two types have been so far identified : -  and  Molecular Action of Estrogen Illustration by Anne Erickson
    • 8. Estrogen Receptor Distribution <ul><li> &  - CNS, blood vessels, bone, heart, breast, ovary, uterus, testes, prostate </li></ul><ul><li> - Liver </li></ul><ul><li> - Lungs, kidney, bladder, intestines </li></ul>www.freelivedoctor.com Adopted from George GJM Kuiper et al <ul><li>Based on the level of ER mRNA levels </li></ul><ul><li>Awaits confirmation till subtype specific monoclonal antibodies are available </li></ul>Molecular Action of Estrogen
    • 9. Molecular Action of Estrogen <ul><li> homodimer </li></ul><ul><li> homodimer </li></ul><ul><li> &  heterodimer </li></ul><ul><li>Non-genomic effects </li></ul>www.freelivedoctor.com Adopted from George GJM Kuiper et al Alternating estrogen signaling pathways
    • 10. Molecular Action of Estrogen www.freelivedoctor.com Different response in different tissues Adopted from Lewis J. Kleinsmith Ph.D, Donna Kerrigan M.S., Jeanne Kelly
    • 11. Molecular Action of www.freelivedoctor.com Estradiol Adapted from Howell A, Osborne CK, Morris C, Wakeling AE. ICI 182, 780 (Faslodex®), development of a novel, &quot;pure&quot; antiestrogen. Cancer 2000; 89: 819.
    • 12. Molecular Action of www.freelivedoctor.com SERM (Tamoxifen) Adapted from Howell A, Osborne CK, Morris C, Wakeling AE. ICI 182, 780 (Faslodex ® ), development of a novel, &quot;pure&quot; antiestrogen. Cancer 2000; 89: 819.
    • 13. Molecular Action of www.freelivedoctor.com Estrogen Receptor Down regulator A Promising Area of Research Adapted from Howell A, Osborne CK, Morris C, Wakeling AE. ICI 182, 780 (Faslodex ® ), development of a novel, &quot;pure&quot; antiestrogen. Cancer 2000; 89: 819.
    • 14. Mechanism of Tissue Response - Summary www.freelivedoctor.com Oestrogen Receptor Ligand Complex Oestrogen Receptor Ligand E / SERM / PE/ERD DNA Oestrogen Response element Gene Transcription Tissue Response Coregulatory Proteins  /  Agonistic & or Antagonistic AF 1 & 2
    • 15. Selective Ostrogen Receptor Modulators www.freelivedoctor.com Estrogens Anti Estrogens SERMs SERMs- designed to act in specific ways at each of the oestrogen receptor sites in different tissues ERDR Phytoestrogens
    • 16. <ul><li>Designer drugs which exhibit tissue specific desirable Estrogenic & Antiestrogenic actions in different tissues </li></ul><ul><li>“ Designer Estrogens” </li></ul><ul><li>“ Fantasy Estrogens” </li></ul>Selective Ostrogen Receptor Modulators www.freelivedoctor.com They have the potential of providing a new paradigm for maintaining the health of women.
    • 17. www.freelivedoctor.com <ul><li>Mer 25 (1958) </li></ul><ul><li>Clomiphene </li></ul><ul><li>Tamoxifen </li></ul><ul><ul><li>Toremifene </li></ul></ul><ul><ul><li>Droloxifene </li></ul></ul><ul><ul><li>Iodoxifene </li></ul></ul><ul><li>Raloxifene </li></ul><ul><li>Ormeloxifene </li></ul>As of Today Selective Ostrogen Receptor Modulators
    • 18. www.freelivedoctor.com The Ideal Selective Ostrogen Receptor Modulator The perfect SERM The ideal SERM is one that prevents bone loss, has no risk of uterine or breast cancer, a +ve effect on lipids & cardiovascular system, relieves PMS and maintains cognitive function of the brain The Search goes on Adopted from – Rita de Cassia M Dardes & V Craig Jordan
    • 19. www.freelivedoctor.com The Ideal Selective Ostrogen Receptor Modulator The perfect SERM TISSUE Endometrium Breast Vagina Bone Liver/CVS CNS Perfect AE AE E E E E E-Estrogenic, AE-Anti Estrogenic Tamo E AE AE E E AE Ralo AE AE AE E E + E? Ormelo AE  AE  E  E  E  E  The Search goes on
    • 20. Tamoxifen <ul><li>The first true SERM. </li></ul><ul><li>In use for breast cancer treatment since 1968, 10m patient use years. </li></ul><ul><li>Approved for prophylactic use in1997. </li></ul><ul><li>Beneficial effect on osteoporosis. </li></ul><ul><li>Effect on CVS +? </li></ul><ul><ul><li>Lipid profile +. </li></ul></ul>www.freelivedoctor.com
    • 21. Tamoxifen <ul><li>Has many undesirable E / AE actions. </li></ul><ul><ul><li>E in uterus – risk of End. Cancer. </li></ul></ul><ul><ul><li>Alleged as a carcinogen. </li></ul></ul><ul><ul><li>AE in vagina, CNS? </li></ul></ul><ul><li>Unsatisfactory safety/toxicity profile. </li></ul><ul><li>Gave boost to the continued research for SERMs. </li></ul><ul><li>Under evaluation-star trial-6/99, 22000 women for 5-10 yrs. </li></ul>www.freelivedoctor.com
    • 22. Raloxifene <ul><li>Originally approved (1998) for use for treatment and prevention of osteoporosis. </li></ul><ul><li>Subsequently (1999) approved for breast cancer prevention after ‘MORE’ study </li></ul><ul><li>Improved safety profile than Tamoxifen </li></ul><ul><li>Cardiovascular effects are unequivocal & under evaluation. </li></ul>www.freelivedoctor.com
    • 23. Raloxifene <ul><li> Risk of venous thromboembolism </li></ul><ul><li>No effect on endometrium. AE on vagina </li></ul><ul><li>Effect on CNS?. No improvement in cognitive function </li></ul><ul><li>Does not relieve PM hot flashes </li></ul><ul><li>Possible future use as HRT?? </li></ul><ul><li>Is on evaluation- STAR trial </li></ul>www.freelivedoctor.com
    • 24. ORMELOXIFENE www.freelivedoctor.com The individual elements of the molecular structure give a tissue selectivity- different DNA transcriptions in different tissues Estrogen agonist Estrogen antagonist Chemical Name- Trans -7-methyl-2-2-dimethyl-3-phenyl-4(4-(2-pyroldinoethoxy)phenyl(-chroman hydrochloride), related to centchroman The perfect SERM
    • 25. <ul><li>Enhanced tissue selectivity </li></ul><ul><ul><li>Basic amine side chain – uterine AE action </li></ul></ul><ul><ul><li>Pyrolidine base – highest degree of antagonistic action </li></ul></ul><ul><ul><li>Benzopyran group – agonistic action & binding affinity </li></ul></ul><ul><li>Very strong binding affinity to ER </li></ul><ul><ul><li>Quick & potent action </li></ul></ul><ul><li>Slow nuclear build up & prolonged retention of ER </li></ul><ul><ul><li>Long half life & prolonged action </li></ul></ul>www.freelivedoctor.com The perfect SERM ORMELOXIFENE
    • 26. ORMELOXIFENE www.freelivedoctor.com An optimally designed potent SERM with Varied Tissue Response Oestrogen Antagonist in UTERUS & BREAST Mild Oestrogenic action on Vagina, Bone mineral density, CNS and Serum Lipids No action on Hypothalamic Pituitary Ovarian function, Thyroid, Adrenal. The perfect SERM No Progestational, Androgenic or Antiandrogenic properties
    • 27. ORMELOXIFENE www.freelivedoctor.com Special benefit in perimenopausal women – Relief of PMS Currently indicated for the treatment of Dysfunctional Uterine Bleeding at ANY AGE. Not suitable for women desiring pregnancy Approved for inclusion in National Family Welfare Program, for social marketing. The perfect SERM
    • 28. ORMELOXIFENE <ul><li>Contraindicated in – </li></ul><ul><ul><li>H/O recent liver dysfunction or clinical jaundice </li></ul></ul><ul><ul><li>PCOD </li></ul></ul><ul><ul><li>Cervical Dysplasia & Chronic Cervicitis </li></ul></ul><ul><ul><li>Hypersensitivity to the drug </li></ul></ul><ul><ul><li>Allergic conditions </li></ul></ul><ul><ul><li>Nursing mothers </li></ul></ul><ul><ul><li>Chronic illness </li></ul></ul>www.freelivedoctor.com The perfect SERM
    • 29. ORMELOXIFENE www.freelivedoctor.com Has an excellent safety profile,very well tolerated & practically without any undesirable side effects Easy to administer - 60mg tablet twice a week ( Sunday & Wednesday) for 12 weeks followed by one tablet of 60mg once weekly The perfect SERM
    • 30. ORMELOXIFENE www.freelivedoctor.com <ul><li>Currently being evaluated for use in the treatment and prevention of: - </li></ul><ul><ul><li>Breast Cancer </li></ul></ul><ul><ul><li>Osteoporosis </li></ul></ul><ul><li>Possible future use: - </li></ul><ul><ul><li>Menopause management </li></ul></ul><ul><ul><li>Fibromyoma </li></ul></ul><ul><ul><li>Endometriosis and Adenomyosis </li></ul></ul><ul><ul><li>Contraceptive </li></ul></ul>The perfect SERM
    • 31. ORMELOXIFENE www.freelivedoctor.com WARNING: - <ul><li>Indian contribution </li></ul><ul><li>Not introduced in the international arena </li></ul><ul><li>Not approved by FDA </li></ul><ul><li>Not yet fully evaluated - extensive clinical trials needed </li></ul>The perfect SERM
    • 32. www.freelivedoctor.com “ There is no cure for birth and death save to enjoy the interval” --Santayana Selective Estrogen Receptor Modulators promise to make the interval really enjoyable for women, though the final words on Mode Of Action of Estrogen, Estrogen Receptors and SERMs are yet to be said.
    • 33. www.freelivedoctor.com Women have reason to say SERMs have the potential of providing a new paradigm for maintaining the health of women.

    ×